**Correction to: BMC Infect Dis**

**https://doi.org/10.1186/s12879-019-4374-8**

After publication of the original article \[[@CR1]\], we were notified that a column needed to be removed from Table [1](#Tab1){ref-type="table"}.

The correct version can be found below: Table 1Results of HIV molecular testing, Antigen/Antibody screening assay, and CD4 count from time first presentation (June 2014) to initiation of ARV therapyTimeViral Load\
(RNA copies/ml)Forth Generation Antigen/Antibody HIV Test\
(s/co --relative quantity of HIV Ab)Confirmatory TestCD4+ T Cells/uL (%)Viral LoadSCAARCHITECT (S/Co)VIDAS (S/Co)GSINNO-LIAJun 201471550^a^--*1* ^*b*^NEGNEG----Oct 2014\<  200--11.1^c^13.72 ^c^--gp41 (3+), p31 (1+), p24 (3+), p17 (1+) ^c^--Nov 2014\<  40----------616 (45%)Dec 2014--------------Oct 2015\<  40----------459 (46%)Apr 2016\<  40----------558 (40%)Sep 2016--0.84^d^----------Antiretroviral therapy commenced September 2016 ^d^ Oct 16------------585 (47%)Fourth Generation HIV Antigen/Antibody test: ARCHITECT® Abbott; VIDAS® BioMerieux; *GS = GeneScreen*® Bio-Rad, *INNO-LIA, Fujirebio*®*SCA* Single copy assay, *S/Co* Signal/cutoff^a^ Retrospective molecular test on stored sample from June 2014^b^ Read as equivocal value at time of testing^c^ Positive test^d^ ARV commenced on clinical grounds-patient presented with furunculosis

Furthermore, the words "Hiv specific antibody levels and" should be deleted from the 'Case presentation' section in the Abstract.

The original article has been corrected.

The publisher apologies for the inconvenience.
